309 related articles for article (PubMed ID: 20593920)
1. An enhanced thirteen-week bioassay as an alternative for screening for carcinogenesis factors.
Cohen SM
Asian Pac J Cancer Prev; 2010; 11(1):15-7. PubMed ID: 20593920
[TBL] [Abstract][Full Text] [Related]
2. Evolution of the uses of rats and mice for assessing carcinogenic risk from chemicals in humans.
Ward JM
Asian Pac J Cancer Prev; 2010; 11(1):18. PubMed ID: 20593921
[TBL] [Abstract][Full Text] [Related]
3. An enhanced 13-week bioassay: an alternative to the 2-year bioassay to screen for human carcinogenesis.
Cohen SM
Exp Toxicol Pathol; 2010 Sep; 62(5):497-502. PubMed ID: 19616417
[TBL] [Abstract][Full Text] [Related]
4. Human carcinogenic risk evaluation: an alternative approach to the two-year rodent bioassay.
Cohen SM
Toxicol Sci; 2004 Aug; 80(2):225-9. PubMed ID: 15129023
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary.
Cohen SM
Toxicol Pathol; 2010 Apr; 38(3):487-501. PubMed ID: 20215581
[TBL] [Abstract][Full Text] [Related]
6. Medium-term bioassays in rats for rapid detection of the carcinogenic potential of chemicals.
Shirai T; Hirose M; Ito N
IARC Sci Publ; 1999; (146):251-72. PubMed ID: 10353390
[No Abstract] [Full Text] [Related]
7. Alternative models for carcinogenicity testing: weight of evidence evaluations across models.
Cohen SM
Toxicol Pathol; 2001; 29 Suppl():183-90. PubMed ID: 11695556
[TBL] [Abstract][Full Text] [Related]
8. A perspective on current and future uses of alternative models for carcinogenicity testing.
Goodman JI
Toxicol Pathol; 2001; 29 Suppl():173-6. PubMed ID: 11695554
[TBL] [Abstract][Full Text] [Related]
9. Expectations for transgenic rodent cancer bioassay models.
Ashby J
Toxicol Pathol; 2001; 29 Suppl():177-82. PubMed ID: 11695555
[TBL] [Abstract][Full Text] [Related]
10. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
11. In Vitro-In Vivo Carcinogenicity.
Steinberg P
Adv Biochem Eng Biotechnol; 2017; 157():81-96. PubMed ID: 27506831
[TBL] [Abstract][Full Text] [Related]
12. Commentary on "Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary".
Long GG
Toxicol Pathol; 2010 Apr; 38(3):502-5. PubMed ID: 20124495
[No Abstract] [Full Text] [Related]
13. Mouse-specific carcinogens: an assessment of hazard and significance for validation of short-term carcinogenicity bioassays in transgenic mice.
Battershill JM; Fielder RJ
Hum Exp Toxicol; 1998 Apr; 17(4):193-205. PubMed ID: 9617631
[TBL] [Abstract][Full Text] [Related]
14. Neonatal mouse model: review of methods and results.
McClain RM; Keller D; Casciano D; Fu P; MacDonald J; Popp J; Sagartz J
Toxicol Pathol; 2001; 29 Suppl():128-37. PubMed ID: 11695548
[TBL] [Abstract][Full Text] [Related]
15. Alternatives to the 2-species bioassay for the identification of potential human carcinogens.
Ashby J
Hum Exp Toxicol; 1996 Mar; 15(3):183-202. PubMed ID: 8839204
[TBL] [Abstract][Full Text] [Related]
16. A data-based assessment of alternative strategies for identification of potential human cancer hazards.
Boobis AR; Cohen SM; Doerrer NG; Galloway SM; Haley PJ; Hard GC; Hess FG; Macdonald JS; Thibault S; Wolf DC; Wright J
Toxicol Pathol; 2009 Oct; 37(6):714-32. PubMed ID: 19700658
[TBL] [Abstract][Full Text] [Related]
17. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay.
Flammang TJ; Tungeln LS; Kadlubar FF; Fu PP
Regul Toxicol Pharmacol; 1997 Oct; 26(2):230-40. PubMed ID: 9356286
[TBL] [Abstract][Full Text] [Related]
18. Panel discussion on the application of alternative models to cancer risk assessment.
Pettit SD
Toxicol Pathol; 2001; 29 Suppl():191-5. PubMed ID: 11695557
[TBL] [Abstract][Full Text] [Related]
19. Assessment of human cancer risk: challenges for alternative approaches.
Omenn GS
Toxicol Pathol; 2001; 29 Suppl():5-12. PubMed ID: 11695561
[TBL] [Abstract][Full Text] [Related]
20. Bioassays of shortened duration for drugs: statistical implications.
Kodell RL; Lin KK; Thorn BT; Chen JJ
Toxicol Sci; 2000 Jun; 55(2):415-32. PubMed ID: 10828275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
